SEPLITE® MA940
Scan the QR code
Macroporous type, Styrene, Free base
SEPLITE® MA940 Ion Exchange Resins
Descriptions:
SEPLITE® MA940 is a polystyrene macroporous, weak base anion resin.
MA 940 shows excellent removal ability for natural organic substances or acidic materials from product streams.
Due to its macro porous structure, MA 940 presents an outstanding performance on regeneration efficiency, its strong matrix also ensures its good
feature for resistance of osmotic shock.
Physical and Chemical Characteristics:
| Matrix Structure | Styrene Divinylbenzene copolymer, Macroporous |
| Functional group | Tertiary amine |
| Shipped form | FB |
| Physical Appearance | Ivory spheres |
| Particle size (mm) | 0.315- 1.25 >95% |
| Moisture content (%) | 48-58 |
| Total Capacity(eq/L) | ≥1.50 |
| Bulk Density ( g/l) | 650-750 |
| Density ( g/l) | 1030- 1130 |
| Whole beads count (%) | ≥95 |
Precautions:
Resins should be stored in sealed containers or bags where temperature was above 0℃ in dry conditions without exposure to direct sunlight.
Do not mix ion exchange resin with strong oxidizing agents; otherwise it will cause violent reactions.
In case of eyes contact with resins, rinse eyes immediately with plenty of water, and consult a specialist.
Material and samples must be disposed according to local regulations.
Dry polymers will expand when become wetted and may cause an exothermic reaction.
Spilled materials may be slippery.
SEPLITE® and Monojet™ are registered trademarks of Sunresin New Materials Co. Ltd.
.This information is general information and may differ from that based on actual conditions. For more information about SEPLITE® resins, please contact SUNRESIN® directly.
Free Quote
Product
Application
Contact Us
Sunresin Park,No.135, jinye Road, Xi’an Hi-tech Industrial Development Zone, Shaanxi-710076, China
seplite@sunresin.com
seplite_europe@sunresin.com
+86-29-89182091
Our Product List
Latest News
01
2025 07
Sunresin Bioprocess Materials Achieve DMF Registration, Supporting Global Biopharma Compliance
Sunresin has obtained 10 Drug Master File (DMF) registrations for its chromatography resins used in antibody, vaccine, and gene therapy production. With 9 more products under review, Sunresin provides robust regulatory support for global pharmaceutical customers and accelerates IND/NDA filing efficiency with FDA and EMA compliance.
05
2025 06
Sunresin Secures Australian Patent for Lithium Adsorbent Innovation
Sunresin New Materials Co., Ltd. is pleased to announce that its invention titled “A Lithium Adsorbent and Its Preparation Method” has been officially granted a patent in Australia.
Leave a Message
Please send any questions you want to know, we will reply to you immediately.
Choose File
Submit